PCDH19 rs587784300: Understanding This Genetic Variant
The rs587784300 variant is a rare genetic change located within the PCDH19 gene. It is associated with PCDH19-related epilepsy, a condition characterized by early-onset seizures that primarily affects females due to a unique mechanism of X-linked cellular mosaicism.
What each genotype means
Typical genetic profile
This genotype represents the common, non-variant form of the PCDH19 gene at this location. It is not associated with the specific epilepsy syndrome linked to this variant.
This is the most common genotype found in the general population.
Heterozygous carrier status
This genotype indicates the presence of one copy of the variant. In females, who have two X chromosomes, this can lead to cellular mosaicism where some cells express the normal protein and others do not, a mechanism associated with PCDH19-related epilepsy. Please discuss these results with a genetic counselor or clinician to understand the clinical implications for your specific health history.
This genotype is rare in the general population.
Pathogenic variant carrier
This genotype indicates the presence of the variant on the X chromosome. In females, this is associated with an increased risk for early-onset epilepsy and related neurodevelopmental features. In males, who typically have only one X chromosome, the presence of this variant is often associated with the clinical syndrome, though the expression can be variable. Please consult with a medical professional or genetic specialist to discuss these findings.
This genotype is extremely rare in the general population.
What is the rs587784300 Variant?
The rs587784300 variant is a specific change in the DNA sequence of the PCDH19 gene, which is located on the X chromosome. In genetic databases, this variant is identified by its rsID, a unique reference number used by researchers to track specific locations in the human genome. Because it sits on the X chromosome, the way this variant is inherited and how it manifests clinically is distinct from variants found on non-sex chromosomes. This variant is categorized as a rare genetic finding, meaning it is not commonly observed in the general population. When researchers study this site, they look at how the presence of a different nucleotide at this position might alter the function of the protein the gene is responsible for creating. Understanding the location and nature of this variant is the first step in exploring its potential impact on human health.
The Role of the PCDH19 Gene
The PCDH19 gene provides instructions for making a protein called protocadherin-19. This protein is a member of the cadherin family, which plays a critical role in cell-to-cell communication and adhesion, particularly in the developing brain. By helping cells stick together and organize correctly, protocadherin-19 is essential for the proper formation of neural circuits. When the PCDH19 gene is altered, the resulting protein may not function as expected, which can disrupt the delicate signaling processes between neurons. This disruption is thought to be a primary driver of the neurological symptoms associated with PCDH19-related conditions. Because this gene is located on the X chromosome, its expression is subject to X-inactivation, a process where one of the two X chromosomes in females is silenced in each cell. This biological process is central to why the clinical presentation of PCDH19 variants is so unique.
Research and Clinical Associations
Research has established a strong association between pathogenic variants in PCDH19 and a form of epilepsy known as early infantile epileptic encephalopathy 9 (EIEE9). This condition is characterized by the onset of seizures, often in the first year of life, which may be sensitive to fever and occur in clusters. The evidence for this association is considered moderate to strong in clinical literature, as many cases have been documented in medical studies. A fascinating aspect of this condition is the 'cellular interference' hypothesis: in females, the presence of both normal and mutated cells (due to X-inactivation) creates a mosaic environment that disrupts brain development. Conversely, males who are hemizygous for the mutation often do not show the same clinical features, potentially because they lack this mosaicism. It is important to note that clinical manifestations can be highly heterogeneous, meaning the severity and specific symptoms can vary significantly between individuals, even those with the same genetic variant.
Population Frequency and Interpretation
The rs587784300 variant is classified as rare, meaning it is found at a very low frequency across global populations. Because it is rare, large-scale population studies often have limited data on its exact prevalence. When interpreting genetic reports, it is vital to understand that the presence of a variant does not automatically guarantee a specific health outcome. Genetic testing results should always be interpreted by a qualified healthcare professional, such as a genetic counselor or a medical geneticist, who can place the finding in the context of an individual's personal and family medical history. This information is intended for educational purposes and should not be used to diagnose or treat any medical condition. If you or a family member have questions about a genetic finding, please consult with a clinician to discuss the implications and appropriate next steps for your specific situation.
How common is this variant?
The rs587784300 variant is considered rare across all major ancestral populations, with limited data available in large-scale genomic databases.
Frequently asked questions
What is PCDH19-related epilepsy?
PCDH19-related epilepsy is a genetic condition that typically begins in infancy. It is characterized by clusters of seizures that may be triggered by fever and is often associated with developmental delays.
Why does this condition primarily affect females?
The condition is X-linked, and the disease mechanism requires a mix of both normal and mutated cells. This mosaicism occurs naturally in females due to X-inactivation, whereas males typically have only one type of cell, which may explain why they are often unaffected.
Is this variant a diagnosis?
No, identifying a genetic variant is not the same as a clinical diagnosis. A diagnosis requires a comprehensive evaluation by a medical professional, including a review of symptoms and clinical history.
What should I do if I have this variant?
If you or a family member have been identified as a carrier of this variant, you should discuss the results with a genetic counselor or a neurologist. They can provide personalized guidance based on your specific clinical context.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs587784300?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29